Biotech stories

OpenAI expands its enterprise AI push with a biology-focused model aimed at speeding target discovery, analysis and early drug development.

US AI megadeals push global venture capital to a record USD $330.9 billion as OpenAI, Anthropic and xAI dominate first-quarter funding.

ACTO rolls out role-based AI SuperAgents for life sciences field teams, aiming to speed compliant access to approved content across sales and medical work.

Iran-linked wiper cyber attack cripples Stryker plants, disrupting implant production and locking thousands of staff out of global networks.

Biotech's next leaders will be defined less by scientific breakthroughs and more by diverse teams building resilient clinical infrastructure.

Anthropic rolls out Claude for Healthcare and Life Sciences, adding sector-specific connectors, agent skills and consumer health integrations.

Perforce CTO Rod Cope predicts context and agentic AI will transform coding, jobs and security as ambient systems quietly permeate daily life.

NZTech has rebranded as Tech New Zealand, uniting 16 tech Communities and the wider Tech Alliance under one national ecosystem voice.

Biostate AI's K-Dense Beta, an AI research system, slashes biological research times from years to weeks, proven through Harvard Medical School longevity studies.

Swiss Deep Tech startups have surpassed USD $100 billion in value, boosted by strong venture capital and academic innovation in AI, biotech, and space sectors.

Auckland Mayor unveils Innovation & Technology Alliance to boost collaboration, tech growth, and economic productivity in the city and region.

Atturra has secured the acquisition of Project Delivery Services LLC, known as Kitepipe, for USD $3.15 million, enhancing its Boomi service capabilities.

Danish biotech firm Fuse Vectors has secured USD $5.2 million in pre-seed funding to advance its innovative cell-free gene therapy technology.

Iktos and Cube Biotech have partnered to leverage AI-driven drug discovery and advanced protein technology, targeting the Amylin Receptor for cardiometabolic disorders.

New Relic has been named a Leader in the 2024 Gartner Magic Quadrant for Digital Experience Monitoring, praised for its visionary integrations and customer satisfaction.

Hexaware Technologies and PointCross Life Sciences have launched a Clinical Data Automation solution to streamline data management for the BioPharma and BioTech sectors.

New Relic has been named a Leader in the Gartner Magic Quadrant for Observability Platforms, continuing its unmatched streak since 2012.

Superlab Suisse opens the largest private lab in Switzerland at Basel's Stcki Park, boosting support for life science and biotech startups with state-of-the-art facilities.

Litmaps, a New Zealand AI tool, has expanded its growth to 370,000 global users, preparing for a Series A to expand its academic reach.

Capgemini's new report reveals a six-fold surge in connected health solutions in pharma and biotech since 2021, with organisations expecting 20% of revenue from these services within five years.